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Abstract
The Lkb1 tumour suppressor is a multitasking kinase participating in a range of physiological processes. We have
determined the impact of Lkb1 deficiency on intestinal homeostasis, particularly focussing on secretory cell differentiation
and development since we observe strong expression of Lkb1 in normal small intestine Paneth and goblet cells. We crossed
mice bearing an Lkb1 allele flanked with LoxP sites with those carrying a Cyp1a1-specific inducible Cre recombinase. Lkb1
was efficiently deleted from the epithelial cells of the mouse intestine after intraperitoneal injection of the inducing agent b-
naphthoflavone. Bi-allelic loss of Lkb1 led to the perturbed development of Paneth and goblet cell lineages. These changes
were characterised by the lack of Delta ligand expression in Lkb1-deficient secretory cells and a significant increase in the
levels of the downstream Notch signalling effector Hes5 but not Hes1. Our data show that Lkb1 is required for the normal
differentiation of secretory cell lineages within the intestine, and that Lkb1 deficiency modulates Notch signalling
modulation in post-mitotic cells.
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Introduction
Lkb1 is a tumour suppressor implicated in a wide range of
cellular functions including inhibition of cell proliferation [1,2].
Human LKB1 gene mutations are known to underlie Peutz-Jeghers
syndrome (PJS) characterised by intestinal hamartoma develop-
ment [3,4,5]. It was recently shown that mesenchyme-specific
Lkb1 deletion results in gastrointestinal polyps indistinguishable
from those in PJS, suggesting a non-epithelial origin for intestinal
hamartomas [6]. Functionally, Lkb1 phosphorylates a conserved
threonine in the activation loops of AMPK and a range of AMPK-
related kinases, including MARK kinases [7,8]. The Lkb1/AMPK
system has been proposed to act as an energy sensor to low ATP
levels inhibiting mTOR-mediated cell growth [9]. Lkb1-mediated
phosphorylation of AMPK has also been shown to be essential for
the coordination between epithelial polarity and cellular energy
status, suggesting one potential mechanism underlying Lkb1
tumor suppressor function [10].
To define the role played by Lkb1 in normal intestinal
epithelium, we crossed mice bearing a LoxP flanked Lkb1 cDNA
cassette [11] with mice carrying a Cyp1a1-specific inducible Cre
recombinase construct (AhCre). In the absence of induction, the
AhCre transgene mediates recombination within a proportion of
prostatic epithelial cells, ultimately leading to the development of
prostatic intraepithelial neoplasia (PIN) by 200 days [12]. In
contrast, induction of the AhCre transgene using b-napthoflavone
results in rapid, high penetrance conditional gene deletion in the
epithelium of the murine gastrointestinal tract [13]. This approach
allowed us to generate Lkb1-deficient intestinal epithelium in vivo
and assess the consequences of Lkb1 gene function loss
independently of any delayed phenotype arising in the prostate.
These studies reveal, for the first time, the functional requirement
for Lkb1 in the mouse intestinal epithelium.
Results
Lkb1 loss in the small intestinal epithelium
We generated AhCre
+Lkb1
fl/fl mice which were transgenic for
both the AhCre transgene [13] and were homozygous for a LoxP
flanked Lkb1 cDNA cassette [11]. As a control we used
AhCre
2Lkb1
fl/fl mice lacking the AhCre transgene. Both AhCre-
positive and AhCre-negative mice received a series of b-naptho-
flavone intraperitoneal injections. These injections induced Cre
recombinase expression in the intestinal crypt of Cre-positive
animals [13,14]. Cre-recombinase induction in the intestinal
epithelium of AhCre
+Lkb1
fl/fl mice resulted in the removal of the
entire kinase domain of Lkb1 (exons 4–10 of Lkb1). The regime of
four daily injections produced high levels of recombination within
the intestine as evidenced by qRT-PCR analysis of Lkb1 mRNA
levels, which demonstrated a 16.5 fold reduction (P,0.05, Mann-




Previous studies have shown that Lkb1 mRNA is normally
localised to all epithelial intestinal cells [15]. We show here that
high levels of Lkb1 protein are primarily observed in the cytoplasm
of goblet and Paneth cells in the small intestine (fig 1 A, ‘‘+/+’’).
The induction of Cre expression in AhCre
+Lkb1
fl/fl mice led to the
disappearance of Lkb1 staining from Paneth and goblet cells by
day 6 (fig 1 A, ‘2/2’ ) as assessed by immunohistochemistry. The
level of recombination was more than 95% with very few crypts
retaining Lkb1 staining (fig 1 A, ‘2/2’red circle). Western blot
analysis also confirmed a drastic decrease in Lkb1 levels in the
recombined tissue by day 6 (fig 1 B).
The induction of Cre recombinase by b-naphthoflavone was
also monitored using the surrogate Rosa26R reporter locus [16]. By
day 6, b-galactosidase activity was detected thoroughout the whole
small intestinal tissue of AhCre
+Lkb1
fl/fl mice (fig 1, C, Cre
+). At the
same timepoint there was no detectable b-galactosidase activity in
the intestines of Cre-negative Lkb1
fl/fl mice induced with b-
naphthoflavone (fig 1, C, Cre
2). We observed a high level of
recombination according to both X-Gal staining (fig 1, D) and
anti-b-galactosidase immunostaining (fig 1, E) in both WT and
Lkb1-deficient tissue. Paneth cells are known to have low turnover
rates and would therefore be expected to be b-galactosidase
negative. However, Paneth cells stained positively in Lkb1-
deficient crypts suggesting an increase in the turnover of these
cells in Lkb1-deficient intestines (fig 1, E).
It has been reported previously that the unrecombined mutant
Lkb1 allele is hypomorphic, with an almost 10-fold reduction in
expression in some tissues [11]. Consistent with this, we observed a
reduced level of Lkb1 mRNA in the intestine (P,0.05, Mann-
Whitney U test), however the extent of this reduction was only 1.85
fold and was not associated with any detectable phenotypic change.
Mice harbouring the AhCre transgene have been reported to show
spontaneous levels of recombination (in the absence of b-
naphthoflavone induction) in both the kidney and genitourinary
tract [14,12], but not in the intestine [17]. Previously our group
employed this spontaneous activation of AhCre in the genitourinary
tract of male AhCre
+ Lkb1
fl/fl mice as a powerful model for prostate
cancer [12]. These male mice develop PIN at approximately 200
days [12], and therefore these phenotype would not have impacted
upon our intestinal studies. However, to ensure this was the case we
preferentially used female mice for our experiments. We also
confirmed that the spontaneous background recombination in the
intestine was very low according to both b-galactosidase staining
and also quantitative RT-PCR, which did not identify any
differences between Lkb1 mRNA levels in the intestines of non-
induced Cre-negative and Cre-positive Lkb1
fl/fl mice (data not shown)
Lkb1 loss changes secretory cell morphology
Lkb1 loss led to the enlargement of mucin-secreting cells, as
evidenced by Alcian blue staining (fig 1, A) and also by
haematoxylin and eosin staining (fig 2, A). The average size of a
mucin-secreting cell at day 6 in the control tissue was 23 mm
2 in
the crypt and 33.8 mm
2 in the villus. After the deletion of Lkb1 the
figure rose to 130.7 mm
2 in the crypt and to 94.9 mm
2 in the villus
(P,0.05, Mann-Whitney U test). Muc2 transcript levels were
elevated 5-fold in Lkb1 -deficient tissue according to quantitative
RT-PCR (P,0.05, Mann-Whitney U test).
Mucin secreting cells arising in Lkb1-deficient epithelium
resembled Goblet cells in shape, but they also secreted Lysozyme
(fig 2, B) and contained granules normally specific to Paneth-cells
(fig 2, C). Paneth cells in Lkb1-deficient crypts contained smaller
Lysozyme secreting electron-dense core and larger mucin-
secreting peripheral halo in comparison with WT crypts according
to electron photography (fig 2, C, pictures on the right). These
features are consistent with previous descriptions of Intermediate
cells (intermediate between Goblet and Paneth cells), which are
considered to be rare cells in transition between undifferentiated
cells and more mature secretory cells [18].
Lkb1 loss affects Hes5 expression
Goblet cell differentiation is known to be finely orchestrated by
Notch signalling downstream effectors Hes1 and Hes5 at two
different points and with a different outcome. Hes1 acts at the
progenitor stage promoting enterocyte development and its
deletion shifts the ongoing specification of epithelial cells into
goblet or endocrine cell fate [19]. Hes5, on the contrary, promotes
goblet cell fate but this occurs when the cells have already entered
a post-mitotic stage [20].
We therefore analysed levels of the Notch signalling effectors
Hes1 and Hes5 by Western blot. Hes1 levels did not significantly
change (fig 3, A), but Hes5 was notably elevated (fig 3, A).
Immunohistochemical analysis of control intestines at day 6
showed Hes5-positive cells to be localised predominantly at the
crypt-villus junction (fig 2, B, +/+). Lkb1-deficient samples showed
that Hes5 positive cells also appear at the bottom of the crypt and
amongst Paneth cells (fig 2 B, ‘2/2’).
Lkb1 deletion in the small intestine reduces Delta ligand
levels in secretory cells
The increase in Hes5 expression in Lkb1-negative intestinal
epithelium suggested some dynamic changes in Notch signalling.
Although Notch1 expression did not seem to be affected (data not
shown), we observed a notable change in Delta ligand (Dll1)
expression in Paneth and goblet cells. In control tissues, Dll1 was
seen in virtually all cells of the crypt, with particularly high levels in
Paneth and some goblet cells (fig 2 D, +/+). In Lkb1-deficient
intestines Paneth and goblet cells lost Dll1 staining (fig 2 D, ‘2/
2’). These changes appear to be post-translational, as quantitative
RT-PCR showed no changes in Dll1 mRNA levels. It is known
that Par-1 promotes Delta ligand localization on the lateral
membrane in Drosophila and the depletion of Par-1 disrupts
Notch signalling [21]. Par-1 homologues in mammals are MARK
kinases and they are located downstream of Lkb1 in the
phosphorylation cascade [8]. We found that the phosphorylation
of MARKs (using the antibody against the phosphorylated
activation loop of MARK1, MARK2 and MARK3 kinases) is
significantly reduced in Lkb1-deficient epithelium (fig 3, C). We
examined MARK1 expression and found it to be associated
primarily with goblet and Paneth cells both in the crypt and in the
villus (fig 3, E). Lkb1 deletion did not change this pattern and
secretory cells retained the staining (fig 3, E). Surprisingly we did
not find any change in the phosphorylation of AMPK (Thr 172) by
both western blot (fig 3, C) and immunostaining (fig 4, A). We also
did not observe significant changes in mTOR machinery (fig 4, B,
C, D) known to control cell size [22]. Furthermore, daily
intraperitoneal injections of the mTOR inhibitor Rapamycin
(1 mg/kg) did not reverse the phenotype observed in Lkb1-
deficient intestinal epithelium (fig 4, F).
Discussion
By creating a new mouse model with conditional gene deletion
of Lkb1in the epithelium of the small intestine we have shown that
Lkb1 is necessary for normal intestinal cell differentiation and
maturation. Lkb1 deletion not only induced an increase in the size
of mucin-secreting cells, but also perturbed their morphology.
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PLoS ONE | www.plosone.org 2 January 2009 | Volume 4 | Issue 1 | e4264Alterations in goblet cell number and elevated mucin production
are common features of hamartomas characteristic of PJS [23] and
specifically have been associated with loss of heterozygosity regions
within hamartomas [3]. Normally, mucin is produced in goblet
cells and ‘‘intermediate cells’’ bearing the features of both goblet
and Paneth cells are rare. However, these intermediate cells were
frequently observed upon Lkb1 deletion, as indicated by both
lysozyme staining (fig 2 B) and electron microscopy (fig 2 C).
Secretory granules of Paneth cells from different animals tend to
exhibit bipartite substructure with a peripheral halo of lower
density around a large round central core of high electron density
[24]. According to histochemical studies the central core of a
secretory granule contained basic protein (including lysozyme)
while the peripheral halo was built with acid mucopolysaccharides
[25,26]. In the case of Intermediate Paneth/goblet cells observed
in Lkb1-deficient intestines the mucopolysaccharide halo is
Figure 1. The induction of AhCre recombinase leads to Lkb1 loss in the epithelium of mouse small intestine. A, Immunohistochemical
detection of Lkb1 expression in induced Cre-negative Lkb1 fl/fl (+/+) and induced Cre-positive Lkb1 fl/fl intestinal tissue (‘2/2’). Alcian blue staining
shows the enlargement of mucin-secreting Lkb1-deficient cells. The area marked with red is the unrecombined crypt (they represent less than 5%
from the whole amount of crypts) with both normal Lkb1 staining and Paneth cell morphology in induced Cre-positive Lkb1 fl/fl intestinal tissue (‘2/
2’). B, Western blot analysis of Lkb1 expression in control (1, 2, 3) and recombined (4, 5, 6) tissue at day 6, C, D, E, Cre-mediated recombination is
marked by b-galactosidase reporter gene expression. AHCre-positive gut shows 100% recombination after a regime of b-naphtoflavone injections
compared to no recombination in Cre-negative gut tissue (C), Intestinal sections from Rosa26-positive mice showing the expression of b-
galactosidase gene in Cre-positive tissue (both wt and fl/fl) and the absence of it in Cre-negative tissue via X-Gal staining (D) and immunostaining
with anti-b-Galactosidase antibody (E). Scale bars correspond to 50 mm.
doi:10.1371/journal.pone.0004264.g001
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PLoS ONE | www.plosone.org 3 January 2009 | Volume 4 | Issue 1 | e4264Figure 2. Lkb1 loss changes cell morphology in the small intestine. A, Haematoxylin and eosin staining of intestinal sections of Cre-negative
and recombined Cre+Lkb1fl/fl mice at days 3, 4, 6, 13 and 25 following injection with b-naphthoflavone. Arrows show enlarged mucin-secreting cells
in Lkb1-deficient epithelium. B. Lysozyme immunostaining displaying mislocalised lysozyme-secreting cells (Paneth and Intermediate cells) moving
up Lkb1-deficient crypts (‘2/2’), C, Electron microscopy showing both normal goblet cells and normal Paneth cells in the intestinal tissue of wt mice
(+/+) as well as an intermediate cell localised in the villus (picture on the left). Paneth cells in Lkb1-deficient crypts (‘2/2’, picture on the right) have
visible changes in the bipartite structure of their secretory granules: peripheral halo composed of acid mucopolysaccharides (Spicer et al, 1967) is
enlarged and central core (containing lyzosyme) is smaller in comparison with WT samples (+/+). Scale bars correspond to 50 mm (A, B) or 10 mm (C).
doi:10.1371/journal.pone.0004264.g002
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PLoS ONE | www.plosone.org 4 January 2009 | Volume 4 | Issue 1 | e4264abnormally large and is stained with alcian blue (fig 1, A) whereas
the lysozyme filled central core is significantly smaller than in WT
(fig 2, C). This suggests that the loss of Lkb1 creates a block in the
terminal differentiation of secretory cells.
Intestinal cell specification is known to be directed by Notch
signalling in mice [27,20], Zebrafish [28] and Drosophila [29].
Following Lkb1 deletion, we observed a decrease in Delta1 ligand
(Dll1) expression in goblet and Paneth cells (fig 3, D). In zebrafish
intestines Dll1 homologue is also highly expressed in secretory
cells, and its inhibition leads to secretory cell expansion [28].
Notch signalling is unidirectional and it is mediated by Delta-
expressing cells sending a signal and Notch-expressing cells receiving
it. In Drosophila, Delta/Notch signalling involves repression of Delta
in Notch-expressing cells [30]. Thus, the absence of Delta ligand in
developinggoblet or Panethcells can providea ‘‘signalreceiving’’ role
(Notch-expressing) instead of ‘‘signal sending’’, which in turn can
increase Hes5 expression in them.
PAR1 is known to be important for Delta ligand localisation in
Drosophila [21], so we speculate that the failure in MARK
(mammalian homologue of PAR1) activation in the absence of
Lkb1 may directly lead to the lack of Delta ligand in Lkb1-
deficient Paneth and goblet cells and subsequent deregulation of
secretory cell differentiation.
The regulation of secretory cell fate by the Notch pathway is
dependent on whether the cell is proliferative or post-mitotic. In
proliferative cells, Notch and Hes1 repress a conversion of all
dividing crypt cells into goblet cells and this conversion occurs if
Notch is inhibited [27,31]. Conversely, a very brief induction of
Figure 3. Lkb1-deficiency alters the expression of Notch signalling components and leads to the abnormal intestinal secretory cell
differentiation. A, Western blot analysis of Notch signalling effectors, Hes1 and Hes5 at day 6 in induced Cre-negative Lkb1 fl/fl (+/+) (lanes 1, 2) and
Lkb1-deficient (‘2/2’) intestinal tissue (lane 3, 4), Hes5 expression has a notable increase. B, Immunohistochemistry showing the localisation of Hes5-
positive cells (pointed with red arrows) in Lkb1-deficient crypts (‘2/2’). C, Western blot analysis showing decrease in the phosphorylation of MARK
kinases activation loop in Lkb1-deficient intestine (‘2/2’) while AMPK (Thr 172) phosphorylation levels are intact. D, Delta ligand (Dll1)
immunostaining at day 6 in induced Cre-negative Lkb1 fl/fl (+/+) and Lkb1-deficient (‘2/2’) intestines displaying a decrease in Dll1 expression in
Paneth and goblet cells of Lkb1-deficient intestines. Dll positive cells pointed with red arrows. E, Immunohistochemistry showing the localisation of
Mark1 in goblet and Paneth cells both in WT (+/+) and Lkb1-deficient crypts (‘2/2’), pointed with red arrows. Scale bars correspond to 50 mm. Alcian
Blue stain was performed to show mucin-secreting cells.
doi:10.1371/journal.pone.0004264.g003
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PLoS ONE | www.plosone.org 5 January 2009 | Volume 4 | Issue 1 | e4264Notch pathway drives the differentiation of post-mitotic cells into
mature goblet cells via Hes5 expression [20]. In our studies, we did
not observe changes in overall Hes1 levels, but Hes5 levels were
notably higher, suggesting that Lkb1 deletion is more important
for the differentiation at the post-mitotic stage (fig 3, A).
The failure in secretory cell terminal differentiation after Lkb1
deletion resembled the effects observed after the terminal
differentiation of cell precursors into Paneth cells was blocked
via SV40 T antigen expression [32]. This also led to the
substitution of the mature Paneth cells with intermediate
Paneth/goblet cells showing a decrease in the granule’s electron-
dense core diameter and expansion of the mucinous area [32].
Notch signalling misregulation observed in Lkb1-deficient intes-
tines may also be explained by consequences arising from the
altered terminal differentiation of Paneth cells development.
Clearly, further studies are required to address this possibility.
Although mTOR is a known regulator of the cell size [22] and
Lkb1 can suppress mTOR via AMPK phosphorylation [9] we did
not find evidence of mTOR machinery misregulation in our model
(fig 4) suggesting relatively intact energy sensing mechanisms.
Remarkably, given that Lkb1 has been implicated in mainte-
nance of polarity [33,12], we did not observe any obvious
perturbations in polarity in the intestinal epithelium. It remains
possible that subtle changes are occurring in the absence of Lkb1,
but that these do not result in obvious changes to brush border
structure and nuclear localization.
In summary, we show a complex sequence of events
immediately following loss of function of Lkb1 leading to the
inappropriate differentiation of secretory cells associated with
abnormal expression of Notch pathway elements and consistent
with many features of Notch pathway improper regulation. Our
studies therefore reveal a critical role for Lkb1 in maintaining
normal gut homeostasis.
Materials and Methods
Mice breeding and Cre recombinase induction
All experiments were carried out according to Home Office
regulations. Lkb1
fl/fl mice [11] were crossed to mice harbouring Ah-
Cre transgene [13] and the offspring intercrossed to derive an
outbred colony segregating for C57BL6/J, 129/Ola and C3H
genomes. Mice were genotyped by PCR using DNA extracted with
Puregene DNA extraction kit (Gentra systems) using following
primers: Cre, TGACCGTACACCAAAATTTG (F) and ATTG-
CCCCTGTTTCACTATC (R) (991 bp product); Rosa26R,
CTGGCGTTACCCAACTTAAT (F) and ATAACTGCCGT-
CACTCCAAC (R) (533 bp product); Lkb1 allele: GTA-
CTTCCGCCAGCTGATTGA (F) and AGTGTGACCCCA-
GCTGACCA (R) (320 bp and 280 bp products correspond to
WT and Lkb1
fl alleles respectively). Mice were intraperitoneally
injected with 80 mg/kg b-naphthoflavone (dissolved in corn oil)
once daily for up to 4 days to induce Ah-Cre gene expression and
Figure 4. Lkb1 deletion in mouse intestinal epithelium does not affect mTOR/S6K pathway. A, B, C, D, Immunohistochemical assay
showing no difference in expression of phospho-AMPK-a (Thr172) (A), phospho-mTOR (Ser-2448) (B), phospho-p70 S6 Kinase (Thr421/Ser424) (C),
phospho-S6 Ribosomal Protein (Ser 240–244) (D), between induced Cre-negative Lkb1 fl/fl (+/+) and Lkb1-deficient (‘2/2’) samples at day 6. E,
Haematoxylin and eosin staining of intestinal samples from Lkb1-deficient mice treated and untreated with rapamycin showing no decrease in Lkb1-
deficient phenotypic features in the rapamycin-treated sample. Scale bars correspond to 50 mm.
doi:10.1371/journal.pone.0004264.g004
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fl allele recombination. All times indicated in the text were
related to the time elapsed since the first exposure.
b-Galactosidase analysis
7 cm long gut samples were flushed with cold water, opened out
and fixed with pins on a wax plate. Following a quick fix in 2%
formaldehyde/PBS/0.1% glutaraldehyde, intestines were demuci-
fied and left to stain in X-gal solution overnight (as described in
[14]).Therecombinationwasassessed bybluestainingincryptsand
villi and its efficiency was scored according to previous criteria [13].
Electron Microscopy
Intestinal samples were fixed in 2% paraformaldehyde (w/v),
2% glutaraldehyde (v/v) in cold 0.1 M cacodylate buffer (pH 7.4)
for 2 hours, washed briefly, and then post fixed in cacodylate-
buffered 1% osmium tetroxide containing 1.5% potassium
ferrocyanide for 1 hour. Specimens were washed thoroughly and
then stained en bloc with 2% aqueous uranyl acetate for 1 hour,
dehydrated through ethanol gradient and cleared in propylene
oxide before, embedding in araldite resin. Semi-thin resin sections
(1 mm in thickness) were cut and stained with 1% toluidine blue in
borax to localise the area of interest within the tissue. Further
60 nm sections were cut and collected on formvar-coated 200
mesh copper grids and stained with 2% aqueous uranyl acid (w/v)
and Reynolds lead citrate. Representative areas of gut samples
were then photographed.
RNA Extraction and qRT-PCR analysis
RNA was isolated from intestinal samples of 6–10 week old
littermate mice. 261 cm proximal end sections of the small intestine
were taken to RNAlater
TM (Sigma). Tissues were homogenised in
TRIZOL
TM Reagent (Invitrogen) and extracted using standard
Phenol-chloroformprotocol. Reverse transcription was performed by
using the SuperscriptII reverse transcriptase kit (Invitrogen) and
random hexamers (Invitrogen) according to the manufacturer’s
instructions. DyNAmo SYBR green supermix (Finnzymes, GRI,
Essex, U.K.) was added to appropriate cDNA samples and primers.
Samples were loaded onto a white one-piece thin-wall 96-well PCR
plate (Bioplastics). The PTC-200 Peltier thermal cycler (MJ Research)
and Chromo4 fluorescence detector (MJ Research) were used in
conjunction with Opticon Monitor analysis software (version 2.03,
MJ Research) to calibrate and run the reaction. qRT-PCR was
performed on all samples including reverse transcriptase negative
controls. All the control samples were checked and proved to be
negative on a 2% agarose gel. beta-actin and GAPDH were used as
reference genes. Primer sequences are as follows: Beta-actin,5 9-
CTTCCTCCCTGGAGAAGAGC-39 (forward), 59-AAGGAA-
GGCTGGAAAAGAGC-39 (reverse), GAPDH,5 9-CACTGAG-
CATCTCCCTCACA-39 (forward), 59-GTGGGTGCAGCGAAC-
TTTAT-39 (reverse), Hes1,5 9-TAACGCAGTGTCACCTTCCA-
39 (forward), 59-AAGAGAGAGGTGGGCTAGGG-39 (reverse),
Lkb1 59-CTCCGAGGGATGTTGGAGTA-39 (forward), 59-
GCTTGGTGGGATAGGTACGA-39 (reverse) Muc2 59-ACAT-
CACCTGTCCCGACTTC-39 (forward), 59-GAGCAAGG-
GACTCTGGTCTG-39 (reverse).
All primers used were designed using primer3
TM software.
Reaction conditions were as follows: 95uC3 0s ,6 0 uC3 0s ,7 2 uC




Intestinal tissue (50–100 mg) was snap frozen in liquid nitrogen
and ground using a mortar and a pestle and then solubilised in
500 ml of lysis buffer (50 mM Tris pH 7.5, 100 mM NaCl, 5 mM
EDTA, 5 mM EGTA, 0.5% NP-40, 40 mM b-glycerolphosphate,
0.5 mg/ml each Leupeptin, Pepstatin, Chymostatin, 50 mM NaF,
5m MN a 3VO4, with 1 mM microcystin) for 10–20 minutes on
ice. Insoluble material was removed by centrifugation at 20 g for
10 minutes and supernatants were aliquoted and snap frozen in
liquid nitrogen. Protein concentrations were determined using a
Coomassie based method (Bio-Rad). Equal amounts of cellular
protein (60 mg) were separated on 10% acrilamide gel and
subsequently transferred on Hybond ECL nitrocellulose mem-
brane (Amersham Biosciences). Total protein was visualized with
Poinceau (Sigma). After blocking the membranes in TBS
containing 5% BSA, 0.05% Tween 20, 0.02% NaN3 for 1 hour,
primary antibodies were added in block solution for overnight
incubation at 4uC. After five times five minute washes in TBS,
0.05% Tween 20, the appropriate HRP-conjugated secondary
donkey antibodies (Amersham Biosciences) were added (dilution
1:5000) for 30 minutes. After five washes (five minutes each)
antibody binding was detected using ECL reagent (Amersham
Biosciences). The sources and dilutions of the primary antibodies
used for western blotting analysis are stated in the Supplementary
Table S1.
Immunohistochemistry
Immunohistochemistry was performed on formalin fixed tissue
(Lkb1 immunohistochemistry was performed on methacarn fixed
tissue). 361 cm gut fragments (7–10 cm away from the stomach)
were flushed with water, bound in surgical tape and fixed in
formalin or methacarn for a maximum of 14 hours at 4uC. All
fixed samples were embedded in paraffin and sectioned to 5–6 mm
on poly L-lysine slides for immunohistochemical analysis. Antigen
retrieval was performed by boiling in citrate buffer (LabVision) for
10 minutes at 100uC. The endogenous peroxidase was blocked by
EnVision blocking solution (DakoCytomation) for 5 minutes. The
non-specific binding was blocked for 30 minutes with either 5%
goat serum (DakoCytomation) for the primary rabbit polyclonal
antibodies or 5% rabbit serum (DakoCytomation) for the primary
mouse monoclonal antibodies and primary antibody incubation
was performed at 4uC overnight. The detection was performed
using secondary antibody horseradish peroxidase-labelled polymer
and DAB reagent (DakoCytomation). The sources and dilutions of
the primary antibodies used for immunohistochemical analysis are
stated in the Supplementary Table S2.
Supporting Information
Table S1 Antibodies used for western blot analysis.
Found at: doi:10.1371/journal.pone.0004264.s001 (0.03 MB
DOC)
Table S2 Antibodies used for immunohistochemical analysis.
Found at: doi:10.1371/journal.pone.0004264.s002 (0.03 MB
DOC)
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